Alpaslan COŞAR, Osman Metin İPÇİOĞLU, Ömer ÖZCAN, Mustafa GÜLTEPE

Folate and homocysteine metabolisms and their roles in the biochemical basis of neuropsychiatry

The term 'one-carbon metabolism' is commonly used to describe 3 separate metabolic processes: folate metabolism, the homocysteine remethylation cycle, and the transsulfuration pathway. Folate metabolism concerns the biochemical reactions in which endogenous and exogenous one-carbon units are transferred to tetrahydrofolates. The remethylation cycle is used for the synthesis of methionine from homocysteine with one-carbon units that come from folate. This methionine is then used for the synthesis of S-adenosyl methionine, which is a general donor of methyl groups for many biochemical reactions in the human body. In the transsulfuration pathway, some amino acids and polypeptides, such as cystathionine, cysteine, and glutathione, are synthesized from homocysteine. The kinetics of the enzymes in this pathway are regulated by the substrates of the remethylation cycle. The methylation process has been thought to have an important role in the biochemical basis of neuropsychiatry. An elevated homocysteine level is the most important marker of folate and vitamin B12 deficiencies, and also the most reliable biochemical sign of functional insufficiency. Some neurological and neuropsychiatric diseases, such as psychosis, Alzheimer’s disease, and autism, have been found to be related to disorders of one-carbon metabolism. This review aims to summarize both one-carbon metabolism and its relationships with neuropsychiatric disorders.

Anahtar Kelimeler:

Key words: One-carbon metabolism, folic acid, folate subgroups, homocysteine, vitamin B12, neuropsychiatric disorders

Folate and homocysteine metabolisms and their roles in the biochemical basis of neuropsychiatry

Keywords:

Key words: One-carbon metabolism, folic acid, folate subgroups, homocysteine, vitamin B12, neuropsychiatric disorders,

PDF

___

Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailability. Biochem Mol Med 1995; 55: 43–53.
Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121–138.
Steinberg SE. Mechanisms of folate homeostasis. Am J Physiol 1984; 246: G319–324.
Kane MA, Elwood PC, Portillo RM, Antony AC, Kolhouse JF. The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells. J Biol Chem 1986; 261: 15625–15631.
Sirotnak FM, Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 1999; 19: 91– 1
Antony AC. Folate receptors. Annu Rev Nutr 1996; 16: 501– 5
Antony AC. The biological chemistry of folate receptors. Blood 1992; 79: 2807–2820.
Lee HC, Shoda R, Krall JA, Foster JD, Selhub J, Rosenberry TL. Folate binding protein from kidney brush border membranes contains components characteristic of a glycoinositol phospholipid anchor. Biochemistry 1992; 31: 3236–3243.
Birn H, Selhub J, Christensen EI. Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am J Physiol 1993; 264: C302–310.
Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 1992; 52: 6708–6711.
Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 1986; 83: 5983–5987.
Ifergan I, Jansen G, Assaraf YG. The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis. J Biol Chem 2008; 283: 20687–20695.
Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr 2001; 21: 255–282.
Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J 1990; 4: 1450–1459.
Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 1989; 45: 263–335.
Lin BF, Huang RF, Shane B. Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-gamma-glutamate synthetase. J Biol Chem 1993; 268: 21674–21679.
Picciano MF, Stokstad ELR, Gregory JF, editors. Folic acid metabolism in health and disease. New York: Wiley-Liss; 1995
Matherly LH, Czajkowski CA, Muench SP, Psiakis JT. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2’deoxyuridine antitumor activity in vitro. Cancer Res 1990; 50: 3262–3269.
Yeo EJ, Briggs WT, Wagner C. Inhibition of glycine N-methyltransferase by 5-methyltetrahydrofolate pentaglutamate. J Biol Chem 1999; 274: 37559–37564.
Gregory JF 3rd, Williamson J, Liao JF, Bailey LB, Toth JP. Kinetic model of folate metabolism in nonpregnant women consuming [2H2]folic acid: isotopic labeling of urinary folate and the catabolite para-acetamidobenzoylglutamate indicates slow, intake-dependent, turnover of folate pools. J Nutr 1998; 128: 1896–1906.
Brosnan JT, Jacobs RL, Stead LM, Brosnan ME. Methylation demand: a key determinant of homocysteine metabolism. Acta Biochim Pol 2004; 51: 405–413.
Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992; 55: 131–138.
Gultepe M, Ozcan O, Avsar K, Cetin M, Ozdemir AS, Gok M. Urine methylmalonic acid measurements for the assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem 2003; 36: 275–282.
Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007; 45: 1694–1699.
Baltacı D, Kutlucan A, Öztürk S, Karabulut İ, Ak Yıldırım H, Çeler A, Celbek G, Kara İH. Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and nonmetabolic syndrome: case-control study. Turk J Med Sci 2012; 42: 802– 80
Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 2002; 70: 694–702.
Ipcioglu OM, Ozcan O, Gultepe M, Ates A, Basoglu C, Cakir E. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses. Clin Biochem 2008; 41: 831–835.
Narin F, Coşkun A, Narin N, Baykan A, Onan SH, Coşkun A, Poyrazoğlu M, Erez R. An investigation of changes in ocular blood flow in rabbits with long-term hyperhomocysteinemia using color Doppler ultrasonography. Turk J Med Sci 2011; 41: 1007–1012.
Abacı A, Akelma AZ, Özdemir O, Hızlı Ş, Razi CH, Akın KO. Relation of total homocysteine level with metabolic and anthropometric variables in obese children and adolescents. Turk J Med Sci 2012; 42: 69–76.
Aydın M, Koca C, Uysal S, Totan Y, Yağcı R, Armutcu F, Cücen Z, Yiğitoğlu MR. Serum nitric oxide, asymmetric dimethylarginine, and plasma homocysteine levels in active Behçet’s disease. Turk J Med Sci 2012; 42: 1194–1199.
Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000; 39: 13005– 130
Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998; 157 (Suppl. 2): S40–44.
Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003; 26: 137–146.
McCully KS. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 2009; 39: 219–232.
Cockroft DL. Vitamin deficiencies and neural-tube defects: human and animal studies. Hum Reprod 1991; 6: 148–157.
Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 2002; 22: 1752–1762.
Lovblad K, Ramelli G, Remonda L, Nirkko AC, Ozdoba C, Schroth G. Retardation of myelination due to dietary vitamin B12 deficiency: cranial MRI findings. Pediatr Radiol 1997; 27: 155–158.
Taşkesen M, Yaramış A, Katar S, Gözü Pirinççioğlu AG, Söker M. Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey. Turk J Med Sci 2011; 41: 1091–1096.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113.
Haworth JC, Dilling LA, Surtees RA, Seargeant LE, Lue-Shing H, Cooper BA, Rosenblatt DS. Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 1993; 45: 572–576.
Engelborghs S, Vloeberghs E, Maertens K, Marien P, Somers N, Symons A, Clement F, Ketels V, Saerens J, Goeman J et al. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. Int J Geriatr Psychiatry 2004; 19: 365–370.
Pan WH, Chang YP, Yeh WT, Guei YS, Lin BF, Wei IL, Yang FL, Liaw YP, Chen KJ, Chen WJ. Co-occurrence of anemia, marginal vitamin B 6 , and folate status and depressive symptoms in older adults. J Geriatr Psychiatry Neurol 2012; 25: 170–178.
Ahmed HH, Shousha WG, Hussein RM, Farrag AH. Potential role of some nutraceuticals in the regression of Alzheimer’s disease in an experimental animal model. Turk J Med Sci 2011; 41: 455–466.
Rosenquist TH, Finnell RH. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 2001; 60: 53–61.
Brown AS, Bottiglieri T, Schaefer CA, Quesenberry CP Jr, Liu L, Bresnahan M, Susser ES. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 2007; 64: 31–39.
Smythies JR, Gottfries CG, Regland B. Disturbances of onecarbon metabolism in neuropsychiatric disorders: a review. Biol Psychiatry 1997; 41: 230–233.
Young SN, Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 841– 8
Haidemenos A, Kontis D, Gazi A, Kallai E, Allin M, Lucia B. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1289– 12
Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 2006; 11: 143–149.
Ayesa-Arriola R, Perez-Iglesias R, Rodriguez-Sanchez JM, Mata I, Gomez-Ruiz E, Garcia-Unzueta M, Martinez-Garcia O, Tabares-Seisdedos R, Vazquez-Barquero JL, Crespo-Facorro B. Homocysteine and cognition in first-episode psychosis patients. Eur Arch Psychiatry Clin Neurosci 2012; 262: 557– 5
Ozcan O, Ipcioglu OM, Gultepe M, Basogglu C. Altered red cell membrane compositions related to functional vitamin B(12) deficiency manifested by elevated urine methylmalonic acid concentrations in patients with schizophrenia. Ann Clin Biochem 2008; 45: 44–49.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449– 14
Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, Smith AD. Homocysteine as a predictor of cognitive decline in Alzheimer’s disease. Int J Geriatr Psychiatry 2010; 25: 82–90.
Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000; 71: 993–998.
Serot JM, Christmann D, Dubost T, Bene MC, Faure GC. CSFfolate levels are decreased in late-onset AD patients. J Neural Transm 2001; 108: 93–99.
Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990; 53: 1096–1098.
Currenti SA. Understanding and determining the etiology of autism. Cell Mol Neurobiol 2010; 30: 161–171.
James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 947–956.
Beard CM, Panser LA, Katusic SK. Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 2011; 77: 15–17.
Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39: 319–328.
Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci Lett 2007; 422: 24–29.
Shuang M, Liu J, Jia MX, Yang JZ, Wu SP, Gong XH, Ling YS, Ruan Y, Yang XL, Zhang D. Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. Am J Med Genet B Neuropsychiatr Genet 2004; 131B: 48–